The reduction of hyaluronan in the tumor tissue has been shown to be due to the loss of HAS1 and HAS2, and increased HYAL2, and this associated with poor prognosis and shortened disease-specific survival in melanoma (19, 95). This evidence concerns the gene HAS1 and melanoma.